Submission Details
| 510(k) Number | K980912 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 10, 1998 |
| Decision Date | July 22, 1998 |
| Days to Decision | 134 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
K980912 is an FDA 510(k) clearance for the VCA IGG ELISA TEST SYSTEM. This device is classified as a Epstein-barr Virus, Other (Class I — General Controls, product code LSE).
Submitted by Clark Laboratories, Inc. (Frederick, US). The FDA issued a Cleared decision on July 22, 1998, 134 days after receiving the submission on March 10, 1998.
This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3235.
| 510(k) Number | K980912 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 10, 1998 |
| Decision Date | July 22, 1998 |
| Days to Decision | 134 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
| Product Code | LSE — Epstein-barr Virus, Other |
| Device Class | Class I — General Controls |
| CFR Regulation | 21 CFR 866.3235 |